All Stories

  1. Human herpesvirus 6B glycoprotein B postfusion structure, vulnerability mapping, and receptor recognition
  2. R9AP is a common receptor for EBV infection in epithelial cells and B cells
  3. Structural basis of Epstein-Barr virus gp350 receptor recognition and neutralization
  4. Research landmarks on the 60th anniversary of Epstein-Barr virus
  5. Data from Genomic profiling of radiation-induced sarcomas reveals the immunological characteristics and its response to immune checkpoint blockade
  6. Data from Genomic profiling of radiation-induced sarcomas reveals the immunological characteristics and its response to immune checkpoint blockade
  7. Supplementary Figure S1 from Genomic profiling of radiation-induced sarcomas reveals the immunological characteristics and its response to immune checkpoint blockade
  8. Supplementary Figure S1 from Genomic profiling of radiation-induced sarcomas reveals the immunological characteristics and its response to immune checkpoint blockade
  9. Supplementary Figure S2 from Genomic profiling of radiation-induced sarcomas reveals the immunological characteristics and its response to immune checkpoint blockade
  10. Supplementary Figure S2 from Genomic profiling of radiation-induced sarcomas reveals the immunological characteristics and its response to immune checkpoint blockade
  11. Supplementary Figure S3 from Genomic profiling of radiation-induced sarcomas reveals the immunological characteristics and its response to immune checkpoint blockade
  12. Supplementary Figure S3 from Genomic profiling of radiation-induced sarcomas reveals the immunological characteristics and its response to immune checkpoint blockade
  13. Supplementary Figure S4 from Genomic profiling of radiation-induced sarcomas reveals the immunological characteristics and its response to immune checkpoint blockade
  14. Supplementary Figure S4 from Genomic profiling of radiation-induced sarcomas reveals the immunological characteristics and its response to immune checkpoint blockade
  15. Supplementary Table S1 from Genomic profiling of radiation-induced sarcomas reveals the immunological characteristics and its response to immune checkpoint blockade
  16. Supplementary Table S1 from Genomic profiling of radiation-induced sarcomas reveals the immunological characteristics and its response to immune checkpoint blockade
  17. Supplementary Table S2 from Genomic profiling of radiation-induced sarcomas reveals the immunological characteristics and its response to immune checkpoint blockade
  18. Supplementary Table S2 from Genomic profiling of radiation-induced sarcomas reveals the immunological characteristics and its response to immune checkpoint blockade
  19. Supplementary Table S3 from Genomic profiling of radiation-induced sarcomas reveals the immunological characteristics and its response to immune checkpoint blockade
  20. Supplementary Table S3 from Genomic profiling of radiation-induced sarcomas reveals the immunological characteristics and its response to immune checkpoint blockade
  21. Supplementary Table S4 from Genomic profiling of radiation-induced sarcomas reveals the immunological characteristics and its response to immune checkpoint blockade
  22. Supplementary Table S4 from Genomic profiling of radiation-induced sarcomas reveals the immunological characteristics and its response to immune checkpoint blockade
  23. Discovering broader antiviral strategies: Role of interferon-induced transmembrane proteins in virus infection
  24. A pan-KRAS degrader for the treatment of KRAS-mutant cancers
  25. The structure of HSV-1 gB bound to a potent neutralizing antibody reveals a conservative antigenic domain across herpesviruses
  26. Navigating Epstein–Barr virus autoimmunity: role of NK cells and T cells in multiple sclerosis
  27. Breakthrough for Epstein-Barr virus vaccine development: gB nanoparticle vaccine
  28. A gB nanoparticle vaccine elicits a protective neutralizing antibody response against EBV
  29. mRNA‐based Vaccines Targeting the T‐cell Epitope‐rich Domain of Epstein Barr Virus Latent Proteins Elicit Robust Anti‐Tumor Immunity in Mice
  30. Elucidation of the neutralizing antibody evasion of emergent SARS-CoV-2 Omicron sub-lineages using structural analysis
  31. Data from Genomic Profiling of Radiation-Induced Sarcomas Reveals the Immunologic Characteristics and Its Response to Immune Checkpoint Blockade
  32. Neuropilin 1 is an entry receptor for KSHV infection of mesenchymal stem cell through TGFBR1/2-mediated macropinocytosis
  33. Genomic Profiling of Radiation-Induced Sarcomas Reveals the Immunologic Characteristics and Its Response to Immune Checkpoint Blockade
  34. EphA2 is a functional entry receptor for HCMV infection of glioblastoma cells
  35. Anti‐EBV antibodies: Roles in diagnosis, pathogenesis, and antiviral therapy
  36. How EBV Infects: The Tropism and Underlying Molecular Mechanism for Viral Infection
  37. Protective anti-gB neutralizing antibodies targeting two vulnerable sites for EBV-cell membrane fusion
  38. Induction of Broadly Cross-Reactive Antibody Responses to SARS-CoV-2 Variants by S1 Nanoparticle Vaccines
  39. Molecular characteristics, immune evasion, and impact of SARS-CoV-2 variants
  40. Quadrivalent mosaic HexaPro-bearing nanoparticle vaccine protects against infection of SARS-CoV-2 variants
  41. Vesicular Stomatitis Virus-Based Epstein-Barr Virus Vaccines Elicit Strong Protective Immune Responses
  42. Parallel profiling of antigenicity alteration and immune escape of SARS-CoV-2 Omicron and other variants
  43. A potent and protective human neutralizing antibody targeting a novel vulnerable site of Epstein-Barr virus
  44. PD-1+CXCR5−CD4+ Th-CXCL13 cell subset drives B cells into tertiary lymphoid structures of nasopharyngeal carcinoma
  45. The Status and Prospects of Epstein–Barr Virus Prophylactic Vaccine Development
  46. Immunization with a Self-Assembled Nanoparticle Vaccine Elicits Potent Neutralizing Antibody Responses against EBV Infection
  47. Rapid Development of SARS-CoV-2 Spike Protein Receptor-Binding Domain Self-Assembled Nanoparticle Vaccine Candidates
  48. Association between Antibody Responses to Epstein-Barr Virus Glycoproteins, Neutralization of Infectivity, and the Risk of Nasopharyngeal Carcinoma
  49. R9AP is a functional receptor for Epstein-Barr virus infection in both epithelial cells and B cells
  50. Rapid development of SARS-CoV-2 receptor binding domain-conjugated nanoparticle vaccine candidate
  51. Eliciting women’s preference for prenatal testing in China: a discrete choice experiment
  52. Methylenetetrahydrofolate reductase polymorphisms and colorectal cancer prognosis: A meta‐analysis
  53. The role of a semi-automated NanoVelcro system in capturing circulating tumor cells and evaluating their prognostic value for gestational choriocarcinoma
  54. The effect of exercise during pregnancy on gestational diabetes mellitus in normal-weight women: a systematic review and meta-analysis
  55. Clinical significance of circulating tumor cells in predicting disease progression and chemotherapy resistance in patients with gestational choriocarcinoma
  56. Diagnostic value and lymph node metastasis prediction of a custom‑made panel (thyroline) in thyroid cancer
  57. Role of Circulating Tumor Cells as Prognostic Marker in Patients with Gestational Choriocarcinoma
  58. Hepatocyte growth factor is a prognostic marker in patients with colorectal cancer: a meta-analysis